// App-Quantinova.ai

: Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study

Researchers

Presenter

  • Noemi Puig

Principal Investigators

  • Vania T.M. Hungria

  • Ajai Chari

  • Faith E. Davies

  • Gordon Cook

  • Roman Hajek

  • Kathryn E. Morgan

  • Jim Omel

  • Evangelos Terpos

  • Michael A. Thompson

  • Saad Usmani

  • Jorge Vela-Ojeda

  • Katja Weisel

  • Mira Armour

  • Kaili Ren

  • Dasha Cherepanov

  • Dawn Marie Stull

  • Jesus Berdeja

Medical Centers

  • Tempus Labs, Chicago, IL

  • Hospital Universitario de Salamanca Hematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

  • Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI

  • The Central Nebraska Myeloma Support Group, Grand Island, NE

  • Myeloma Patients Europe, Brussels, Belgium

  • Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  • Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia

  • Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, United Kingdom

  • Perlmutter Cancer Center, NYU Langone, New York, NY

  • Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil

  • Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

  • Levine Cancer Institute, Charlotte, NC

  • Department of Medicine, Division of Blood and Marrow Transplantation, Moores UMAE Especialidades Centro Medico La Raza IMSS, Ciudad de México, Mexico

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece

  • Tennessee Oncology and Sarah Cannon Research Institute, Nashville

Locations

  • United States

  • Brazil

  • Czech Republic

  • Spain

  • Mexico

  • Germany

  • Croatia

  • Greece

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cross-Sectional

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved